Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· January 26, 2026

EP Group's proposed takeover bid for Fnac Darty at a price of €36 per share, in cash

View original at globenewswire.com
EP Group's proposed takeover bid for Fnac Darty at a price of €36 per share, in cash THE DISSEMINATION, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IS NOT AUTHORIZED IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER COUNTRY WHERE SUCH COMMUNICATIO…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • EP Group does not intend to implement a squeeze-out procedure

    80% confidence
  • EP Group intends to pursue the main strategic orientations implemented by the Company and its management team as presented in its Beyond everyday strategic plan

    80% confidence
  • Together with the members of the Board of Directors, we have unanimously welcomed this proposed offer from the Group's largest shareholder. We have mandated Ledouble to conduct an independent appraisal and are starting our work to issue our reasoned opinion to shareholders in the coming weeks, in the best interest of all the Company's stakeholders.

    80% confidence
  • EP Group intends to maintain Fnac Darty's headquarters in France

    80% confidence
  • The offer is expected to be filed with the AMF before the end of the first quarter of 2026

    80% confidence
  • EP Group does not intend to change the Company's dividend policy

    80% confidence
  • EP Group intends to maintain Fnac Darty's management team

    80% confidence
  • With EP Group, the Group's largest shareholder since 2023 through its subsidiary VESA Equity Investment, we have built a relationship of trust over the years that has enabled us to complete the transformative acquisition of Unieuro. Without prejudging the reasoned opinion of the Board of Directors, we welcome this project by our largest shareholder, which shows renewed support for our Beyond everyday plan and our longer-term strategy.

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com